417 related articles for article (PubMed ID: 27067638)
21. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
22. Breast tumor aromatase: functional role and transcriptional regulation.
Chen S; Zhou D; Okubo T; Kao YC; Yang C
Endocr Relat Cancer; 1999 Jun; 6(2):149-56. PubMed ID: 10731103
[TBL] [Abstract][Full Text] [Related]
23. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
Chen D; Reierstad S; Fang F; Bulun SE
Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
[TBL] [Abstract][Full Text] [Related]
24. Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer.
Rižner TL
Mol Cell Endocrinol; 2013 Dec; 381(1-2):124-39. PubMed ID: 23911898
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH).
Okubo T; Truong TK; Yu B; Itoh T; Zhao J; Grube B; Zhou D; Chen S
Cancer Res; 2001 Feb; 61(4):1338-46. PubMed ID: 11245431
[TBL] [Abstract][Full Text] [Related]
27. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
Brueggemeier RW; Díaz-Cruz ES
Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
[TBL] [Abstract][Full Text] [Related]
28. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
29. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of aromatase expression in human breast tissue.
Chen S; Itoh T; Wu K; Zhou D; Yang C
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):93-9. PubMed ID: 12650705
[TBL] [Abstract][Full Text] [Related]
31. Identification of PARP-1, Histone H1 and SIRT-1 as New Regulators of Breast Cancer-Related Aromatase Promoter I.3/II.
Kaiser A; Krüger T; Eiselt G; Bechler J; Kniemeyer O; Huber O; Schmidt M
Cells; 2020 Feb; 9(2):. PubMed ID: 32059481
[TBL] [Abstract][Full Text] [Related]
32. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
33. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.
Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER
Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173
[TBL] [Abstract][Full Text] [Related]
34. Aromatase expression in women's cancers.
Bulun SE; Simpson ER
Adv Exp Med Biol; 2008; 630():112-32. PubMed ID: 18637488
[TBL] [Abstract][Full Text] [Related]
35. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
[TBL] [Abstract][Full Text] [Related]
36. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
37. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
38. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
Kijima I; Ye J; Glackin C; Chen S
Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
[TBL] [Abstract][Full Text] [Related]
39. Tissue-specific estrogen biosynthesis and metabolism.
Simpson ER; Clyne C; Speed C; Rubin G; Bulun S
Ann N Y Acad Sci; 2001 Dec; 949():58-67. PubMed ID: 11795380
[TBL] [Abstract][Full Text] [Related]
40. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
